Transcriptome analysis reveals upregulation of bitter taste receptors in severe asthmatics

…, C Pedroletti, K Daham, M Kupczyk… - European …, 2013 - Eur Respiratory Soc
The causes of severe childhood asthma are poorly understood. Our aim was to define global
patterns of gene expression in children with severe therapy-resistant and controlled asthma…

Asthma research in Europe: a transformative agenda for innovation and competitiveness

…, SL Johnston, M Kupczyk… - European …, 2017 - Eur Respiratory Soc
Asthma is highly prevalent, often starting in infancy and persisting throughout life, and is
associated with high morbidity and burden. It is a major global health challenge with growing …

Identification Of Risk Factors For Frequent Exacerbations In Severe Asthma

M Kupczyk, S Hague, R Middelveld… - A92. SEVERE …, 2012 - atsjournals.org
Rationale: Frequent exacerbations are a poor prognostic sign in asthma. There are few
studies on exacerbations that have followed patients with repeated objective measures over …

Phenotypic predictors of chronic obstructive pulmonary disease exacerbations in the BIOAIR study

K Strandberg, C Janson, B Dahlén, M Kupczyk… - 2016 - Eur Respiratory Soc
Background: A frequent–exacerbation phenotype of chronic obstructive pulmonary disease (COPD)
has been reported but has not yet been clearly defined. Aim: To characterize and …

TH2 specific biomarker profile determines steroid responsiveness in severe asthma

A James, M Kupczyk, J Ono, S Ohta, K Izuhara… - 2013 - Eur Respiratory Soc
Biomarkers able to determine responsiveness to therapy in severe asthma (SA) are needed.
Our goal was to examine the usefulness of periostin, eosinophils and exhaled NO as …

Dna Methylation In The Promoter Of Neuropeptide S Receptor 1 (NPSR1) In Relation To Respiratory Syndromes

LE Johansson, M Kupczyk, C Söderhäll… - A33. GENETIC AND …, 2011 - atsjournals.org
METHODS BIOAIR (Longitudinal Assessment of Clinical Course and BIOmarkers in severe
Chronic AIRway Disease) is a European multicentre study including patients with severe and …

Safety Of The COX-2 Inhibitor Etoricoxib In Allergen-Challenged Asthmatics

…, E Henriksson, B Billing, M Kupczyk… - A37. LIPIDS IN LUNG …, 2012 - atsjournals.org
Results: Etoricoxib treatment did not change pre-challenge baseline lung function (mean±SEM
FEV 3.78±0.20 and 3.82±0.20 after 1 drug and control, respectively), AHR to MCh (Fig 1) …

DNA Methylation Of Neuropeptide S Receptor 1 In Relation To Childhood Asthma And Environmental Factors

…, SE Dahlen, M D'amato, J Kere, M Kupczyk… - … OF LUNG CELL …, 2012 - atsjournals.org
RATIONALE Neuropeptide S receptor 1 () is a strong candidate gene for asthma. Previous
data suggest that environmental factors such as farm NPSR1 exposure can modulate genetic …

Long term effect and allergic sensitization in newly employed workers in laboratory animal facilities

BM Sundblad, L Palmberg, M Kupczyk, K Larsson - 2011 - Eur Respiratory Soc
Background: Allergic reactions are common in laboratory animal workers and one of four
individuals working with laboratory animals report work-related allergic symptoms and may …

[CITATION][C] Controlled oral steroid intervention decreases serum periostin levels in asthmatic patients

A James, J Ono, M Kupczyk, S Ohta… - A110. Late Breaking …, 2013 - atsjournals.org
Aim: Serum periostin levels were measured by ELISA using 2 rat anti-human periostin mAbs
(clones SS18A and SS17B), as described Methods: previously (Okamoto et al. ERJ 2011; …